Currently, there are 108.91M common shares owned by the public and among those 108.84M shares have been available to trade.
The company’s stock has a 5-day price change of -4.64% and -44.77% over the past three months. CE shares are trading -53.53% year to date (YTD), with the 12-month market performance down to -44.43% lower. It has a 12-month low price of $72.78 and touched a high of $172.16 over the same period. CE has an average intraday trading volume of 1.38 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -28.69%, -39.60%, and -48.38% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Celanese Corp (NYSE: CE) shares accounts for 102.54% of the company’s 108.91M shares outstanding.
It has a market capitalization of $7.89B and a beta (3y monthly) value of 1.24. The stock’s trailing 12-month PE ratio is 7.25, while the earnings-per-share (ttm) stands at $9.95. The company has a PEG of 0.32 and a Quick Ratio of 0.76 with the debt-to-equity ratio at 1.83. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.76% over the week and 3.31% over the month.
Earnings per share for the fiscal year are expected to decrease by -8.54%, and 17.04% over the next financial year. EPS should grow at an annualized rate of 22.38% over the next five years, compared to 14.99% over the past 5-year period.
Looking at the support for the CE, a number of firms have released research notes about the stock. UBS stated their Neutral rating for the stock in a research note on November 11, 2024, with the firm’s price target at $161-$97. BMO Capital Markets coverage for the Celanese Corp (CE) stock in a research note released on November 11, 2024 offered a Underperform rating with a price target of $76. Piper Sandler was of a view on November 08, 2024 that the stock is Underweight, while Deutsche Bank gave the stock Buy rating on November 06, 2024, issuing a price target of $135- $110. Wells Fargo on their part issued Equal Weight rating on November 05, 2024.
